These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 22966900

  • 1. Utility of urinary aldosterone measurement in quantitating RAAS activation.
    Atkins CE, Lantis AC, Ames MK, Gardner SY.
    J Vet Pharmacol Ther; 2012 Oct; 35(5):512-5; author reply 516-8. PubMed ID: 22966900
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
    Mochel JP, Fink M, Peyrou M, Soubret A, Giraudel JM, Danhof M.
    Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS.
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [Abstract] [Full Text] [Related]

  • 8. Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio.
    Gardner SY, Atkins CE, Rausch WP, DeFrancesco TC, Chandler DW, Keene BW.
    J Vet Cardiol; 2007 May; 9(1):1-7. PubMed ID: 17689463
    [Abstract] [Full Text] [Related]

  • 9. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
    Giestas A, Palma I, Ramos MH.
    Acta Med Port; 2010 May; 23(4):677-88. PubMed ID: 20687997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The renin-angiotensin-aldosterone system and fibrinolysis.
    Felmeden DC, Lip GY.
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):240-4. PubMed ID: 11881031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, van den Meiracker AH, Danser AH.
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [Abstract] [Full Text] [Related]

  • 16. Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs.
    Sayer MB, Atkins CE, Fujii Y, Adams AK, DeFrancesco TC, Keene BW.
    J Vet Intern Med; 2009 Nov; 23(5):1003-6. PubMed ID: 19737179
    [Abstract] [Full Text] [Related]

  • 17. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C, Buyukhatipoglu H.
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.